Jenna Brunn
Neurology · Uniontown, OHNPI 1306406434
Payments from drug & device makers
Across 157 payments — averaging $100.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$9K
- Sanofi$4K
- TG Therapeutics, Inc.$835
- EMD Serono, Inc.$708
- Biogen$417
- Bristol Myers Squibb$246
- plus $686 from 8 others
What the payments were for
- Consulting fees$11,02570%
- Travel & lodging$9376%
- Food & beverage$3,76724%
- Education$480%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 35 | $9,078 |
| Sanofi | 7 | $3,806 |
| TG Therapeutics, Inc. | 29 | $835 |
| EMD Serono, Inc. | 26 | $708 |
| Biogen | 9 | $417 |
| Bristol Myers Squibb | 21 | $246 |
| Vanda Pharmaceuticals Inc. | 5 | $131 |
| Novartis | 7 | $121 |
| Genentech, Inc. | 4 | $113 |
| Cycle Pharmaceuticals Inc | 6 | $112 |
| AstraZeneca | 4 | $95 |
| Mallinckrodt Hospital Products Inc. | 2 | $75 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| Sandoz | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,776 in reported general payments places this provider in the 70th percentile of 702 neurology providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Kesimpta PenOfatumumab | 37 | $354,624 |
| GlatopaGlatiramer Acetate | 19 | $92,194 |
| Dalfampridine ErDalfampridine | 59 | $11,490 |
| Dimethyl Fumarate | 17 | $8,908 |
| Baclofen | 41 | $4,192 |
| Gabapentin | 46 | $1,259 |
| Pregabalin | 12 | $281 |
| Cyclobenzaprine Hcl | 14 | $213 |
| Nortriptyline Hcl | 11 | $158 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| SandozGlatopa | $16 | $92,19419 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 702 neurology providers in Ohio.
Other neurology in Uniontown
- Jose RafecasUniontown$693K
- Joel VandersluisDayton$12.3M
- Jerry MendellColumbus$11.5M
- Lawrence GoldstickDayton$6.9M
- Douglas ScharreColumbus$6.8M
- Robert BermelCleveland$6.4M
- Aaron BosterColumbus$6.3M
- Ryan DrakeCanton$5.5M
- Aram ZabetiCincinnati$5.3M
- Mark StillmanIndependence$4.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.